Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

α1-Adrenoceptor agonist methoxamine inhibits base excision repair via inhibition of apurinic/apyrimidinic endonuclease 1 (APE1)

A. Kohutova, D. Münzova, M. Pešl, V. Rotrekl

. 2023 ; 73 (2) : 281-291. [pub] 20230612

Jazyk angličtina Země Polsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23011073

Methoxamine (Mox) is a well-known α1-adrenoceptor agonist, clinically used as a longer-acting analogue of epinephrine. 1R,2S-Mox (NRL001) has been also undergoing clinical testing to increase the canal resting pressure in patients with bowel incontinence. Here we show, that Mox hydrochloride acts as an inhibitor of base excision repair (BER). The effect is mediated by the inhibition of apurinic/apyrimidinic endonuclease APE1. We link this observation to our previous report showing the biologically relevant effect of Mox on BER - prevention of converting oxidative DNA base damage to double-stranded breaks. We demonstrate that its effect is weaker, but still significant when compared to a known BER inhibitor methoxyamine (MX). We further determined Mox's relative IC50 at 19 mmol L-1, demonstrating a significant effect of Mox on APE1 activity in clinically relevant concentrations.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23011073
003      
CZ-PrNML
005      
20230801132809.0
007      
ta
008      
230718s2023 pl f 000 0|eng||
009      
AR
024    7_
$a 10.2478/acph-2023-0012 $2 doi
035    __
$a (PubMed)37307375
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a Kohutova, Aneta $u 1Masaryk University, Faculty of Medicine, Department of Biology 625 00, Brno, Czech Republic
245    10
$a α1-Adrenoceptor agonist methoxamine inhibits base excision repair via inhibition of apurinic/apyrimidinic endonuclease 1 (APE1) / $c A. Kohutova, D. Münzova, M. Pešl, V. Rotrekl
520    9_
$a Methoxamine (Mox) is a well-known α1-adrenoceptor agonist, clinically used as a longer-acting analogue of epinephrine. 1R,2S-Mox (NRL001) has been also undergoing clinical testing to increase the canal resting pressure in patients with bowel incontinence. Here we show, that Mox hydrochloride acts as an inhibitor of base excision repair (BER). The effect is mediated by the inhibition of apurinic/apyrimidinic endonuclease APE1. We link this observation to our previous report showing the biologically relevant effect of Mox on BER - prevention of converting oxidative DNA base damage to double-stranded breaks. We demonstrate that its effect is weaker, but still significant when compared to a known BER inhibitor methoxyamine (MX). We further determined Mox's relative IC50 at 19 mmol L-1, demonstrating a significant effect of Mox on APE1 activity in clinically relevant concentrations.
650    _2
$a lidé $7 D006801
650    _2
$a methoxamin $7 D008729
650    12
$a oprava DNA $7 D004260
650    12
$a adrenalin $7 D004837
650    _2
$a adrenergní receptory $7 D011941
650    _2
$a endonukleasy $7 D004720
655    _2
$a časopisecké články $7 D016428
700    1_
$a Münzova, Dita $u 1Masaryk University, Faculty of Medicine, Department of Biology 625 00, Brno, Czech Republic
700    1_
$a Pešl, Martin $u 1Masaryk University, Faculty of Medicine, Department of Biology 625 00, Brno, Czech Republic $u 2International Clinical Research Center (ICRC), St.Anne's University hospital in Brno, 625 00, Brno, Czech Republic $1 https://orcid.org/0000000187041005 $7 xx0143722
700    1_
$a Rotrekl, Vladimir $u 1Masaryk University, Faculty of Medicine, Department of Biology 625 00, Brno, Czech Republic $u 2International Clinical Research Center (ICRC), St.Anne's University hospital in Brno, 625 00, Brno, Czech Republic $1 https://orcid.org/0000000212980849 $7 jk01102795
773    0_
$w MED00000116 $t Acta pharmaceutica (Zagreb, Croatia) $x 1846-9558 $g Roč. 73, č. 2 (2023), s. 281-291
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37307375 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801132805 $b ABA008
999    __
$a ok $b bmc $g 1963467 $s 1197338
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 73 $c 2 $d 281-291 $e 20230612 $i 1846-9558 $m Acta pharmaceutica $n Acta Pharm $x MED00000116
LZP    __
$a Pubmed-20230718

Najít záznam

Citační ukazatele

Možnosti archivace